Search Results - "Beauclair, L"

Refine Results
  1. 1

    A simple PCR method for sexing Japanese quail Coturnix japonica at hatching by Coustham, V., Godet, E., Beauclair, L.

    Published in British poultry science (01-02-2017)
    “…1. The quail is a potentially important avian model for molecular studies; a major drawback is the inability to sex visually before 3 weeks of age. Molecular…”
    Get full text
    Journal Article
  2. 2

    Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching by Margolese, Howard C, Wolf, Yaël, Desmarais, Julie Eve, Beauclair, Linda

    Published in International clinical psychopharmacology (01-05-2010)
    “…Generic formulations of medications are marketed as therapeutically equivalent and less expensive than branded ones. Multiple studies and case reports have…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Valproic acid and panic disorder by Primeau, F, Fontaine, R, Beauclair, L

    Published in Canadian journal of psychiatry (01-04-1990)
    “…Valproic acid (VA), an anticonvulsant which increases GABAergic transmission was given to patients suffering from recurrent panic attacks. Ten consecutive…”
    Get more information
    Journal Article
  7. 7

    Switching from Brand‐Name to Generic Psychotropic Medications: A Literature Review by Desmarais, Julie Eve, Beauclair, Linda, Margolese, Howard C.

    Published in CNS neuroscience & therapeutics (01-12-2011)
    “…SUMMARY Generic medications do not undergo the rigorous approval process required of original medications. Their effectiveness and safety is expected to be…”
    Get full text
    Journal Article
  8. 8

    Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 2: Incidence and Management Strategies in Patients with Schizophrenia by Margolese, Howard C, Chouinard, Guy, Kolivakis, Theodore T, Beauclair, Linda, Miller, Robert, Annable, Lawrence

    Published in Canadian journal of psychiatry (01-10-2005)
    “…Objective: Tardive dyskinesia (TD), the principal adverse effect of long-term conventional antipsychotic treatment, can be debilitating and, in many cases,…”
    Get full text
    Book Review Journal Article
  9. 9

    Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 1: Pathophysiology and Mechanisms of Induction by Margolese, Howard C, Chouinard, Guy, Kolivakis, Theodore T, Beauclair, Linda, Miller, Robert

    Published in Canadian journal of psychiatry (01-08-2005)
    “…Objective: Tardive dyskinesia (TD) is the principal adverse effect of long-term treatment with conventional antipsychotic agents. Several mechanisms may exist…”
    Get full text
    Book Review Journal Article
  10. 10

    Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala by Csernansky, J G, Mellentin, J, Beauclair, L, Lombrozo, L

    Published in Biological psychiatry (1969) (01-02-1988)
    “…Limbic seizures developed in rats following daily electrical stimulation of the basolateral nucleus of the amygdala. Animals were designated as "kindled" after…”
    Get more information
    Journal Article
  11. 11

    Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada by Williams, Richard, Chandrasena, Ranjith, Beauclair, Linda, Luong, Doanh, Lam, Annette

    Published in Neuropsychiatric disease and treatment (01-01-2014)
    “…To assess outcomes over 24 months in Canadian patients with schizophrenia initiated on risperidone long-acting injection (RLAI) and participating in the…”
    Get full text
    Journal Article
  12. 12

    A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression by Chouinard, G, Saxena, B M, Nair, N P, Kutcher, S P, Bakish, D, Bradwejn, J, Kennedy, S H, Sharma, V, Remick, R A, Kukha-Mohamad, S A

    Published in Journal of affective disorders (01-10-1994)
    “…In a 6-week double-blind study, 220 patients with major depression (mostly outpatients) were randomly assigned to receive a fixed dose of brofaromine 150 mg…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients by Chouinard, G, Jones, B, Remington, G, Bloom, D, Addington, D, MacEwan, G W, Labelle, A, Beauclair, L, Arnott, W

    Published in Journal of clinical psychopharmacology (01-02-1993)
    “…In a double-blind study, 135 inpatients with a diagnosis of chronic schizophrenia were randomly assigned to 8 weeks of treatment with one of six parallel…”
    Get more information
    Journal Article
  16. 16

    Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia by ADDINGTON, Donald, ADDINGTON, Jean, PATTEN, Scott, REMINGTON, Gary, MOAMAI, Javad, LABELLE, Alain, BEAUCLAIR, Linda

    Published in Journal of clinical psychopharmacology (01-02-2002)
    “…The effectiveness of selective serotonin reuptake inhibitors for depression in remitted schizophrenia has not been clearly demonstrated. A randomized,…”
    Get full text
    Journal Article
  17. 17

    Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies by Chouinard, G, Saxena, B M, Nair, N P, Kutcher, S P, Bakish, D, Bradwejn, J, Kennedy, S H, Sharma, V, Remick, R A, Kukha-Mohamad, S A

    Published in Clinical neuropharmacology (1993)
    “…Brofaromine is a new, reversible, and selective type-A monoamine oxidase inhibitor (MAOI) that also has serotonin reuptake inhibitory properties. Its dual…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder by MARGOLESE, Howard C, CHOUINARD, Guy, BEAUCLAIR, Linda, BELANGER, Marie-Claire

    Published in Journal of clinical psychopharmacology (01-08-2002)
    “…A 3-year open-label study was conducted to determine the long-term safety and efficacy of quetiapine monotherapy in schizophrenia and schizoaffective…”
    Get full text
    Journal Article
  20. 20